Participated · Series A · Oct 2025

Lila Sciences develops an AI-driven platform that trains models on scientific literature across material sciences, chemistry and life sciences and generates experimental hypotheses. The company pairs those model outputs with laboratory setups to experimentally validate and close the loop between prediction and reproducible results. Reporting says Lila aims for a domain‑crossing, general-purpose science enablement stack rather than narrowly focused tools. Financially, it has completed a reported $200 million seed, emerged from stealth last year, and closed a $350 million Series A in October that lifted its valuation above $1.3 billion. Current reporting describes Lila negotiating an approximately $2 billion financing to scale compute, inference and laboratory capacity and to accelerate partner programs. The firm's growth narrative emphasizes standardizing experiment and feedback loops to make discovery repeatable and scalable.

Participated · Equity · May 2021

LifeQ is an Atlanta-based provider of business-grade biometrics and health information derived from wearable devices and sensors. The company generates 24/7 biometrics and near-clinical-grade health information to detect health problems earlier, manage chronic and acute conditions, and support prevention. LifeQ uses these data streams to build health and wellness solutions for consumer, business, and clinical applications and offers GDPR-compliant products. LifeQ’s technology is integrated by wearable-device makers, insurers, reinsurers, health-tech companies, clinicians, researchers, and analytics firms. The company has commercial relationships with device and consumer brands including Samsung, Xiaomi, Fossil Group, Montblanc, Motorola, Suunto, and HannoverRe. LifeQ announced it secured $47M in funding to support its continued product and commercial development.

Participated · Series A · Mar 2019

Founded in 2017, CesiumAstro designs and manufactures full-stack, software-defined communications payloads, processors, and complete small satellites. Its core Element platform combines modular, in-house-built hardware with AI that optimizes signals in real time, allowing operators to reconfigure missions after launch. The technology has been flight-proven on eight SpaceX launches and targets dense low-Earth-orbit constellations as well as defense applications. By integrating payloads, satellites, and processors under one roof, the company aims to shorten upgrade cycles and reduce costs compared with legacy providers. With fresh capital, CesiumAstro will scale U.S. manufacturing, open a 270,000-square-foot headquarters near Austin, and increase hiring in the United States, United Kingdom, Germany, and Japan. The firm also plans to accelerate launches of its Element satellites, advance its AI capabilities, and pursue additional defense contracts through at least 2027.